|
VRE infections: 600 mg oral/IV q12h x
14-28 days.
Nosocomial pneumonia, complicated skin and skin structure infections, community-acquired pneumonia including concurrent
bacteremia: 600 mg q12h x 10-14 days.
Uncomplicated skin and skin structure infections: 400 mg orally q12h x 10-14 days.
|